- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The mobility aids industry has witnessed rapid growth in the past few years, mainly due to developments in allied fields that affect material, design, and control considerations of locomotion aiding devices. University and industrial researchers have also been consistently working toward many developments, which are leading to the manufacture of new bioabsorbable coatings that facilitate better implant fixation. In addition advances in medicine increase life span and the booming old age population hikes demand for these devices.
Frost & Sullivan ( http://www.ti.frost.com ) finds that Advancements in Mobility Aids provides an overview of the mobility aids and rehabilitation devices and an in-depth analysis on the market drivers and industry challenges. It also includes a section on strategies that provide the reader with some useful tips that could be adapted to the design and make the device marketable and biocompatible.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the Advancements in Mobility Aids, then send an e-mail to Melina Trevino - Corporate Communications at with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.
"Mobility aids are increasingly finding application in the treatment of people afflicted with neurodegenerative diseases, as well as those who have been immobilized by accidents," says Frost & Sullivan Research Analyst Abhishek Dutta. "Mobility aids are also gaining acceptance as cost-effective physiotherapy devices, rehabilitation assistive tools, and as medical devices that render efficient, comfortable, ergonomic yet biocompatible systems."
The number of people requiring rehabilitatory medical attention is increasing globally, primarily due to an increase in the number of accidents, old age disabilities, and greater physical exertion in extreme modes of athletics. The rise in the number of patients requiring mobility aids is proving to be another key factor for industrial development.
Non-invasive biosensing is another area that is likely to disrupt current methodology of diagnostics, as it provides a pain free, cost-effective, yet sensitive biosensing modality, which can overlap and surpass present invasive and point of care biosensing methods.
However, an implant inside the human body will always remain an alien object to the interior physiology of the body, irrespective of its treatment or coating of material. Hence, immunogenic (the physiological self-protection system) reactions can be suppressed or made non-reactive only for a certain period of time.
Nevertheless, the inertness created by the additional coatings on implants wear out after a period of time. Once this happens, the implant is immediately rendered toxic to the body. Hence, the only option is complete natural compatibility, which at the moment, is unreachable.
"A predominant problem with every implantable mobility aid is bio-incompatibility of the implant material and also microbial infection during the surgical insertion," explains Dutta. "This kind of infection may lead to failure of the implant or even other fatal heath hazards."
With the advent of nanotechnology, mobility aids have received a boost, since many new concepts such as self-targeting brain and neuronal implants were introduced. These new techniques hint at invasively attaching themselves at specific locations of the nervous system and providing automated in-vivo neuronal therapy. These new technologies could effectively overcome biocompatibility issues and lead to increased commercial adoption. However, high investments are required in the development of nanotherapeutics, which has promised to be a disruptive technology once it reaches the commercial stage.
Advancements in Mobility Aids is part of the Technical Insights Subscription, and it includes a thorough examination of the mobility aids markets. Interviews are available to the press.
Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com
For more information, please click here
Frost & Sullivan
Melina Trevino, 210-247-2440
Corporate Communications – North America
José María Jantus, + 54-11-4777- 9951
Corporate Communications - Latin America
F: + 54-11-4777-0071
Radhika Menon Theodore
Corporate Communications – Europe
Jasminder Kaur, 65.6890.0937
Corporate Communications – Asia Pacific
Shwetha Thomas, +91 22 4001 3429
Corporate Communications – South Asia & Middle East
F: +91 22 2832 4713
Sharmin Jassal, +61 2 8247 8900
Corporate Communications – Australia & New Zealand
F: +61 2 9252 8066
Amelia Wong, +86 21 5407 5783, ext. 8669 or
M: +86 13621724823
Corporate Communications – China
Patrick Cairns, +27 21 680 3274
Corporate Communications – Africa
F: +27 21 680 3296
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers